Showing results (2141-2150 of 2,197) with videos related to
Sort By:
Pageof 220
Public Health Reports (Washington, D.C. : 1974)|February 1, 2017
A Large Community Outbreak of Legionnaires' Disease Associated With a Cooling Tower in New York City, 2015Don Weiss, Christopher Boyd, Jennifer L Rakeman, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 5, 2022
Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19Flonza Isa, Eduardo Forleo-Neto, Jonathan Meyer, et al.Nature Genetics|August 22, 2017
A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancerPaz Polak, Jaegil Kim, Lior Z Braunstein, et al.International Journal of Radiation Oncology, Biology, Physics|July 7, 2018
Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain MetastasesPaul W Sperduto, Brian J Deegan, Jing Li, et al.Neuro-Oncology|April 29, 2017
Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapyCassie N Kline, Nancy M Joseph, James P Grenert, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2026
Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk MeningiomaRupesh Kotecha, Mei-Yin Polley, Michael A Vogelbaum, et al.Blood Cancer Discovery|October 15, 2021
COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic CentersMalin Hultcrantz, Joshua Richter, Cara A Rosenbaum, et al.Nature Medicine|February 5, 2025
Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trialSaad Z Usmani, Thierry Facon, Vania Hungria, et al.The New England Journal of Medicine|December 17, 2020
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19David M Weinreich, Sumathi Sivapalasingam, Thomas Norton, et al.Nature Communications|January 13, 2021
Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesisTeng Gao, Ryan Ptashkin, Kelly L Bolton, et al.Pageof 220